ID   PRDX6_HUMAN             Reviewed;         224 AA.
AC   P30041; A8JZY7; P32077; Q5TAH4; Q5ZEZ8;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-MAY-2017, entry version 187.
DE   RecName: Full=Peroxiredoxin-6;
DE            EC=1.11.1.15;
DE   AltName: Full=1-Cys peroxiredoxin;
DE            Short=1-Cys PRX;
DE   AltName: Full=24 kDa protein;
DE   AltName: Full=Acidic calcium-independent phospholipase A2;
DE            Short=aiPLA2;
DE            EC=3.1.1.-;
DE   AltName: Full=Antioxidant protein 2;
DE   AltName: Full=Liver 2D page spot 40;
DE   AltName: Full=Non-selenium glutathione peroxidase;
DE            Short=NSGPx;
DE            EC=1.11.1.9;
DE   AltName: Full=Red blood cells page spot 12;
GN   Name=PRDX6; Synonyms=AOP2, KIAA0106;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8999971; DOI=10.1074/jbc.272.4.2542;
RA   Kim T.-S., Sundaresh C.S., Feinstein S.I., Dodia C., Skach W.R.,
RA   Jain M.K., Nagase T., Seki N., Ishikawa K., Nomura N., Fisher A.B.;
RT   "Identification of a human cDNA clone for lysosomal type Ca2+-
RT   independent phospholipase A2 and properties of the expressed
RT   protein.";
RL   J. Biol. Chem. 272:2542-2550(1997).
RN   [2]
RP   ERRATUM.
RA   Kim T.-S., Sundaresh C.S., Feinstein S.I., Dodia C., Skach W.R.,
RA   Jain M.K., Nagase T., Seki N., Ishikawa K., Nomura N., Fisher A.B.;
RL   J. Biol. Chem. 272:10981-10981(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9050990; DOI=10.1038/sj.onc.1200905;
RA   Frank S., Munz B., Werner S.;
RT   "The human homologue of a bovine non-selenium glutathione peroxidase
RT   is a novel keratinocyte growth factor-regulated gene.";
RL   Oncogene 14:915-921(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Bone marrow;
RX   PubMed=7788527; DOI=10.1093/dnares/2.1.37;
RA   Nagase T., Miyajima N., Tanaka A., Sazuka T., Seki N., Sato S.,
RA   Tabata S., Ishikawa K., Kawarabayasi Y., Kotani H., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. III.
RT   The coding sequences of 40 new genes (KIAA0081-KIAA0120) deduced by
RT   analysis of cDNA clones from human cell line KG-1.";
RL   DNA Res. 2:37-43(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (OCT-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Fetal brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-22.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [11]
RP   PROTEIN SEQUENCE OF 2-22; 25-53; 85-106; 133-142; 145-155; 163-173 AND
RP   175-199, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [12]
RP   PROTEIN SEQUENCE OF 2-15.
RC   TISSUE=Liver;
RX   PubMed=1286669; DOI=10.1002/elps.11501301201;
RA   Hochstrasser D.F., Frutiger S., Paquet N., Bairoch A., Ravier F.,
RA   Pasquali C., Sanchez J.-C., Tissot J.-D., Bjellqvist B., Vargas R.,
RA   Appel R.D., Hughes G.J.;
RT   "Human liver protein map: a reference database established by
RT   microsequencing and gel comparison.";
RL   Electrophoresis 13:992-1001(1992).
RN   [13]
RP   PROTEIN SEQUENCE OF 2-13.
RC   TISSUE=Erythrocyte;
RX   PubMed=8313871; DOI=10.1002/elps.11501401183;
RA   Golaz O., Hughes G.J., Frutiger S., Paquet N., Bairoch A.,
RA   Pasquali C., Sanchez J.-C., Tissot J.-D., Appel R.D., Walzer C.,
RA   Balant L., Hochstrasser D.F.;
RT   "Plasma and red blood cell protein maps: update 1993.";
RL   Electrophoresis 14:1223-1231(1993).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 14-99.
RA   Dominguez O., Lombardia L.;
RT   "DNA probes built and sequenced for microarrays hybridisations.";
RL   Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   CHARACTERIZATION, AND MUTAGENESIS.
RX   PubMed=9497358; DOI=10.1074/jbc.273.11.6303;
RA   Kang S.W., Baines I.C., Rhee S.G.;
RT   "Characterization of a mammalian peroxiredoxin that contains one
RT   conserved cysteine.";
RL   J. Biol. Chem. 273:6303-6311(1998).
RN   [16]
RP   CHARACTERIZATION, AND MUTAGENESIS.
RX   PubMed=10893423; DOI=10.1074/jbc.M005073200;
RA   Chen J.-W., Dodia C., Feinstein S.I., Jain M.K., Fisher A.B.;
RT   "1-Cys peroxiredoxin, a bifunctional enzyme with glutathione
RT   peroxidase and phospholipase A2 activities.";
RL   J. Biol. Chem. 275:28421-28427(2000).
RN   [17]
RP   OVEROXIDATION AT CYS-47.
RX   PubMed=12059788; DOI=10.1042/BJ20020525;
RA   Wagner E., Luche S., Penna L., Chevallet M., van Dorsselaer A.,
RA   Leize-Wagner E., Rabilloud T.;
RT   "A method for detection of overoxidation of cysteines: peroxiredoxins
RT   are oxidized in vivo at the active-site cysteine during oxidative
RT   stress.";
RL   Biochem. J. 366:777-785(2002).
RN   [18]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH STH.
RX   PubMed=16186110; DOI=10.1074/jbc.M506116200;
RA   Gao L., Tse S.-W., Conrad C., Andreadis A.;
RT   "Saitohin, which is nested in the tau locus and confers allele-
RT   specific susceptibility to several neurodegenerative diseases,
RT   interacts with peroxiredoxin 6.";
RL   J. Biol. Chem. 280:39268-39272(2005).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-89, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-44, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [21]
RP   INTERACTION WITH APEX1, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=19188445; DOI=10.1128/MCB.01337-08;
RA   Vascotto C., Fantini D., Romanello M., Cesaratto L., Deganuto M.,
RA   Leonardi A., Radicella J.P., Kelley M.R., D'Ambrosio C., Scaloni A.,
RA   Quadrifoglio F., Tell G.;
RT   "APE1/Ref-1 interacts with NPM1 within nucleoli and plays a role in
RT   the rRNA quality control process.";
RL   Mol. Cell. Biol. 29:1834-1854(2009).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-63 AND LYS-209, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-44, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [25]
RP   INTERACTION WITH FAM168B.
RX   PubMed=20716133; DOI=10.1111/j.1582-4934.2010.01134.x;
RA   Mishra M., Akatsu H., Heese K.;
RT   "The novel protein MANI modulates neurogenesis and neurite-cone
RT   growth.";
RL   J. Cell. Mol. Med. 15:1713-1725(2011).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S.,
RA   Fischer-Posovszky P., Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion
RT   profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [27]
RP   CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-44, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [31]
RP   CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS], AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   PubMed=9587003; DOI=10.1038/nsb0598-400;
RA   Choi H.-J., Kang S.W., Yang C.-H., Rhee S.G., Ryu S.-E.;
RT   "Crystal structure of a novel human peroxidase enzyme at 2.0-A
RT   resolution.";
RL   Nat. Struct. Biol. 5:400-406(1998).
CC   -!- FUNCTION: Involved in redox regulation of the cell. Can reduce
CC       H(2)O(2) and short chain organic, fatty acid, and phospholipid
CC       hydroperoxides. May play a role in the regulation of phospholipid
CC       turnover as well as in protection against oxidative injury.
CC   -!- CATALYTIC ACTIVITY: 2 R'-SH + ROOH = R'-S-S-R' + H(2)O + ROH.
CC   -!- CATALYTIC ACTIVITY: 2 glutathione + H(2)O(2) = glutathione
CC       disulfide + 2 H(2)O.
CC   -!- SUBUNIT: Homotetramer. Interacts with GSTP1; mediates PRDX6
CC       glutathionylation and regeneration. May interact with HTR2A (By
CC       similarity). Interacts with APEX1 and STH. May interact with
CC       FAM168B. {ECO:0000250, ECO:0000269|PubMed:16186110,
CC       ECO:0000269|PubMed:19188445, ECO:0000269|PubMed:20716133}.
CC   -!- INTERACTION:
CC       P29991:- (xeno); NbExp=3; IntAct=EBI-2255129, EBI-8826747;
CC       P09211:GSTP1; NbExp=2; IntAct=EBI-2255129, EBI-353467;
CC       P54274:TERF1; NbExp=2; IntAct=EBI-2255129, EBI-710997;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16186110,
CC       ECO:0000269|PubMed:19188445}. Lysosome {ECO:0000250}. Cytoplasmic
CC       vesicle {ECO:0000250}. Note=Also found in lung secretory
CC       organelles. {ECO:0000250}.
CC   -!- MISCELLANEOUS: The active site is the redox-active Cys-47 oxidized
CC       to Cys-SOH. Unlike 2-Cys peroxiredoxins, PRDX6 conserves only this
CC       peroxidatic cysteine. To regenerate and activate the enzyme, the
CC       oxidized form is directly reduced to cysteine by glutathione and
CC       not thioredoxin.
CC   -!- MISCELLANEOUS: Irreversibly inactivated by overoxidation of Cys-47
CC       (to Cys-SO(3)H) upon oxidative stress.
CC   -!- SIMILARITY: Belongs to the AhpC/TSA family. Rehydrin subfamily.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS SNPs;
CC       URL="http://egp.gs.washington.edu/data/prdx6/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D14662; BAA03496.1; -; mRNA.
DR   EMBL; DQ230990; ABB02185.1; -; Genomic_DNA.
DR   EMBL; AL139142; CAI20936.1; -; Genomic_DNA.
DR   EMBL; AK289352; BAF82041.1; -; mRNA.
DR   EMBL; CH471067; EAW90944.1; -; Genomic_DNA.
DR   EMBL; BC035857; AAH35857.1; -; mRNA.
DR   EMBL; BC053550; AAH53550.1; -; mRNA.
DR   EMBL; AJ844621; CAH59743.1; -; mRNA.
DR   CCDS; CCDS1307.1; -.
DR   RefSeq; NP_004896.1; NM_004905.2.
DR   UniGene; Hs.120; -.
DR   UniGene; Hs.731505; -.
DR   PDB; 1PRX; X-ray; 2.00 A; A/B=1-224.
DR   PDB; 5B6M; X-ray; 2.50 A; A/B/C/D/E/F=1-224.
DR   PDB; 5B6N; X-ray; 2.90 A; A/B/C/D/E/F=1-224.
DR   PDBsum; 1PRX; -.
DR   PDBsum; 5B6M; -.
DR   PDBsum; 5B6N; -.
DR   ProteinModelPortal; P30041; -.
DR   SMR; P30041; -.
DR   BioGrid; 114956; 80.
DR   IntAct; P30041; 23.
DR   MINT; MINT-4999165; -.
DR   STRING; 9606.ENSP00000342026; -.
DR   DrugBank; DB03814; 2-(N-Morpholino)-Ethanesulfonic Acid.
DR   DrugBank; DB02325; Isopropyl Alcohol.
DR   SwissLipids; SLP:000001691; -.
DR   PeroxiBase; 4426; Hs1CysPrx01.
DR   iPTMnet; P30041; -.
DR   PhosphoSitePlus; P30041; -.
DR   SwissPalm; P30041; -.
DR   BioMuta; PRDX6; -.
DR   DMDM; 1718024; -.
DR   DOSAC-COBS-2DPAGE; P30041; -.
DR   OGP; P30041; -.
DR   REPRODUCTION-2DPAGE; IPI00220301; -.
DR   REPRODUCTION-2DPAGE; P30041; -.
DR   SWISS-2DPAGE; P30041; -.
DR   EPD; P30041; -.
DR   PaxDb; P30041; -.
DR   PeptideAtlas; P30041; -.
DR   PRIDE; P30041; -.
DR   TopDownProteomics; P30041; -.
DR   DNASU; 9588; -.
DR   Ensembl; ENST00000340385; ENSP00000342026; ENSG00000117592.
DR   GeneID; 9588; -.
DR   KEGG; hsa:9588; -.
DR   CTD; 9588; -.
DR   DisGeNET; 9588; -.
DR   GeneCards; PRDX6; -.
DR   H-InvDB; HIX0028696; -.
DR   HGNC; HGNC:16753; PRDX6.
DR   HPA; CAB008663; -.
DR   HPA; HPA006983; -.
DR   MIM; 602316; gene.
DR   neXtProt; NX_P30041; -.
DR   OpenTargets; ENSG00000117592; -.
DR   PharmGKB; PA134992760; -.
DR   eggNOG; KOG0854; Eukaryota.
DR   eggNOG; COG0450; LUCA.
DR   GeneTree; ENSGT00550000074794; -.
DR   HOGENOM; HOG000022346; -.
DR   HOVERGEN; HBG105234; -.
DR   InParanoid; P30041; -.
DR   KO; K11188; -.
DR   OMA; QLTDNYS; -.
DR   OrthoDB; EOG091G0IWK; -.
DR   PhylomeDB; P30041; -.
DR   TreeFam; TF105183; -.
DR   BRENDA; 1.11.1.15; 2681.
DR   Reactome; R-HSA-3299685; Detoxification of Reactive Oxygen Species.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SIGNOR; P30041; -.
DR   ChiTaRS; PRDX6; human.
DR   EvolutionaryTrace; P30041; -.
DR   GeneWiki; PRDX6; -.
DR   GenomeRNAi; 9588; -.
DR   PRO; PR:P30041; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000117592; -.
DR   CleanEx; HS_PRDX6; -.
DR   ExpressionAtlas; P30041; baseline and differential.
DR   Genevisible; P30041; HS.
DR   GO; GO:0035578; C:azurophil granule lumen; TAS:Reactome.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0047499; F:calcium-independent phospholipase A2 activity; IMP:CAFA.
DR   GO; GO:0004602; F:glutathione peroxidase activity; IMP:CAFA.
DR   GO; GO:0051920; F:peroxiredoxin activity; IEA:UniProtKB-EC.
DR   GO; GO:0042803; F:protein homodimerization activity; IMP:CAFA.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   GO; GO:0098869; P:cellular oxidant detoxification; IMP:CAFA.
DR   GO; GO:0046475; P:glycerophospholipid catabolic process; IMP:CAFA.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; IEA:Ensembl.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0006979; P:response to oxidative stress; IMP:CAFA.
DR   GO; GO:0000302; P:response to reactive oxygen species; TAS:Reactome.
DR   InterPro; IPR000866; AhpC/TSA.
DR   InterPro; IPR024706; Peroxiredoxin_AhpC-typ.
DR   InterPro; IPR019479; Peroxiredoxin_C.
DR   InterPro; IPR012336; Thioredoxin-like_fold.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   Pfam; PF10417; 1-cysPrx_C; 1.
DR   Pfam; PF00578; AhpC-TSA; 1.
DR   PIRSF; PIRSF000239; AHPC; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   PROSITE; PS51352; THIOREDOXIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Antioxidant; Complete proteome; Cytoplasm;
KW   Cytoplasmic vesicle; Direct protein sequencing; Disulfide bond;
KW   Hydrolase; Lipid degradation; Lipid metabolism; Lysosome;
KW   Multifunctional enzyme; Oxidoreductase; Peroxidase; Phosphoprotein;
KW   Redox-active center; Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|PubMed:1286669,
FT                                ECO:0000269|PubMed:8313871,
FT                                ECO:0000269|Ref.11}.
FT   CHAIN         2    224       Peroxiredoxin-6.
FT                                /FTId=PRO_0000135102.
FT   DOMAIN        5    169       Thioredoxin. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00691}.
FT   ACT_SITE     32     32       For phospholipase activity.
FT   ACT_SITE     47     47       Cysteine sulfenic acid (-SOH)
FT                                intermediate.
FT   MOD_RES      44     44       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      63     63       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      89     89       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:15592455}.
FT   MOD_RES     209    209       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     209    209       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:O08709}.
FT   DISULFID     47     47       Interchain; in linked form.
FT                                {ECO:0000250}.
FT   MUTAGEN      32     32       S->A: Loss of AIPLA2 activity, but no
FT                                effect on NSGPX activity.
FT   MUTAGEN      47     47       C->S: Loss of NSGPX activity, but no
FT                                effect on AIPLA2 activity.
FT   STRAND       15     18       {ECO:0000244|PDB:1PRX}.
FT   STRAND       21     24       {ECO:0000244|PDB:1PRX}.
FT   HELIX        25     29       {ECO:0000244|PDB:1PRX}.
FT   STRAND       32     40       {ECO:0000244|PDB:1PRX}.
FT   HELIX        45     62       {ECO:0000244|PDB:1PRX}.
FT   TURN         63     65       {ECO:0000244|PDB:1PRX}.
FT   STRAND       66     74       {ECO:0000244|PDB:1PRX}.
FT   HELIX        76     89       {ECO:0000244|PDB:1PRX}.
FT   STRAND      102    104       {ECO:0000244|PDB:1PRX}.
FT   HELIX       109    113       {ECO:0000244|PDB:1PRX}.
FT   STRAND      117    122       {ECO:0000244|PDB:5B6M}.
FT   STRAND      124    126       {ECO:0000244|PDB:1PRX}.
FT   STRAND      128    130       {ECO:0000244|PDB:5B6M}.
FT   STRAND      133    137       {ECO:0000244|PDB:1PRX}.
FT   STRAND      141    148       {ECO:0000244|PDB:1PRX}.
FT   STRAND      151    153       {ECO:0000244|PDB:5B6N}.
FT   HELIX       157    173       {ECO:0000244|PDB:1PRX}.
FT   STRAND      175    177       {ECO:0000244|PDB:1PRX}.
FT   STRAND      187    189       {ECO:0000244|PDB:1PRX}.
FT   HELIX       195    201       {ECO:0000244|PDB:1PRX}.
FT   STRAND      219    221       {ECO:0000244|PDB:1PRX}.
SQ   SEQUENCE   224 AA;  25035 MW;  017D955F0FEEDFBC CRC64;
     MPGGLLLGDV APNFEANTTV GRIRFHDFLG DSWGILFSHP RDFTPVCTTE LGRAAKLAPE
     FAKRNVKLIA LSIDSVEDHL AWSKDINAYN CEEPTEKLPF PIIDDRNREL AILLGMLDPA
     EKDEKGMPVT ARVVFVFGPD KKLKLSILYP ATTGRNFDEI LRVVISLQLT AEKRVATPVD
     WKDGDSVMVL PTIPEEEAKK LFPKGVFTKE LPSGKKYLRY TPQP
//
